A top-ranking Food and Drug Administration official, responsible for overseeing the approvals of the new vaccines now rolling out for this fall and winter’s three respiratory virus threats, said this …
As classes start back up, so do the cases of sickness that so often seem to accompany back-to-school season. But experts say there are ways to help keep students protected. …
Expectant parents could soon have another new option this fall to protect their newborns from RSV, or respiratory syncytial virus, the most common cause of hospitalization in American infants, after …
It may still feel like summer, but the fall is quickly approaching — along with the risk of seasonal viruses. On “CBS Mornings” Monday, Dr. Céline Gounder, a CBS News medical …
Many babies should get a shot soon after birth to protect them from RSV, or respiratory syncytial virus, a panel of the Centers for Disease Control and Prevention’s outside advisers …
The Food and Drug Administration announced Monday it had approved a new kind of immunization to protect babies from RSV, or respiratory syncytial virus. The drug, nirsevimab, is one of …
The first vaccines to guard against the respiratory illness RSV will soon be available for some older adults, ages 60 and over, after the CDC formally backed recommendations for the shots. …